Obinutuzumab beta for aquaporin-4-positive neuromyelitis optica spectrum disorder: a phase 3 randomized controlled trial. (nature.com)

Authors: Wu L … Huang D Journal: Nature Medicine Published: 2026-08-10 DOI: https://doi.org/10.1038/s41591-026-04583-4